Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin-Reference-Cited by-同舟云学术

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin

Published:2011-05 Issue:5 Volume:54 Page:866-871
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Scherzer Thomas-Matthias,Hofer Harald,Staettermayer Albert Friedrich,Rutter Karoline,Beinhardt Sandra,Steindl-Munda Petra,Kerschner Heidrun,Kessler Harald H.,Ferenci Peter

Publisher

Elsevier BV

Subject

Hepatology

Reference32 articles.

1. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

2. Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection;Lagging;Hepatology,2008

3. Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C;von Wagner;Gastroenterology,2005

4. A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C;Yu;Gut,2007

5. Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study;Dalgard;Hepatology,2004

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens;Biomedicine & Pharmacotherapy;2019-08

2. IL‐28β gene polymorphism determines virological response to PEGylated interferon therapy in hepatitis C virus genotype 4 Egyptian patients;Journal of Cellular Biochemistry;2018-11-18

3. A Closing Chapter: Hepatitis C Genotype 3 Elimination in Liver Transplant; Sofosbuvir/Daclatasvir in a Hard-to-Treat Population;Experimental and Clinical Transplantation;2018-02

4. Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects;Virus Research;2018-01

5. Analysis of the sensitivity of the impact resonance frequency test as a tool to determine the elastic properties of bituminous materials;Materiales de Construcción;2017-07-26